California DTSC's Alternatives Analysis Guide Version 1.0 Slated For Public Discussion

The cosmetics industry has yet to be affected by California's Safer Consumer Products regulation, but if a cosmetic product/chemical combination is included in the next round of Priority Product selections, companies will have the DTSC's heavily criticized – and largely unchanged – Alternatives Analysis Guide to steer their compliance efforts.

California Road sign

The California Department of Toxic Substances Control issued version 1.0 of its Safer Consumer Products Alternatives Analysis Guide in June, and changes made to the document since the release of a draft in late 2016 are not likely to satisfy industry stakeholders.

Industry members will have a chance to voice their concerns at a July 17-18 public meeting of the DTSC's Green...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

Cloudy Tariff Conditions Expected To Linger In US

 

White House announces president extends deadline he set in April for other countries to make new tariff deals from July 9 to Aug. 1, when the administration will start sending letters warning other countries that higher tariffs could take effect.

ECHA Adds Two Cosmetic/Personal Care Silicones To REACH Candidate List

 

ECHA has added two silicone ingredients used in cosmetics and personal care products to the REACH Candidate List as they are persistent and have bioaccumulative properties, requiring companies to notify customers and update safety data sheets if concentrations exceed 0.1%.

MoCRA Implementation Delay Creates More Legal Exposure For Stakeholders – Attorney

 

The delay in implementation of MoCRA is seen by many companies as a temporary reprieve, but it does create more legal uncertainty, says attorney Marissa Alkhazov of law firm Buchalter.

FDA’s FY 2026 Budget Request Lacks New Policy Proposals

 
• By 

The White House requested $6.8bn for the FDA, down 3.9% from the current funding level, but does not propose any legislative changes. In previous years, the agency used the budget process to seek statutory fixes specific to generic drugs and shortages.

More from Policy & Regulation

Cosmetics Europe Pushes Commission To Lower Industry’s UWWTD Costs

 
• By 

The European Commission plans to conduct an updated study that could reallocate extended producer responsibility costs under its Urban Wastewater Treatment Directive, a step welcomed by industry after an analysis concludes the directive vastly overestimates cosmetics’ contribution to toxic waste.

‘Off-Label’ Beauty Hacks: Navigating the Risks of Consumer-Driven Innovation

 
• By 

Guest authors Rachel Raphael, partner at Morgan, Lewis & Bockius, LLP and associates at the firm, Elizabeth Bresnahan and Kathryn Ignash, advise beauty companies on how to navigate the legal risks associated with consumers ‘off-label’ beauty hacks.

MoCRA Implementation Delay Creates More Legal Exposure For Stakeholders – Attorney

 

The delay in implementation of MoCRA is seen by many companies as a temporary reprieve, but it does create more legal uncertainty, says attorney Marissa Alkhazov of law firm Buchalter.